Plate Nº 91 · recorded November 15, 2026
Health & Medicine ResearchReported finding
Stents Offer No Long-Term Heart Attack Protection in Stable Patients
A 25-year COURAGE follow-up in JAMA finds stable heart patients given stents face the same long-term death and heart attack risk as those on medicines alone: 93.3% versus 91%.
By Marcus Bennett3 min read576 words
In brief
- Estimated death-or-heart-attack rate by 25 years: 93.3% with procedure vs 91% with medicines alone — not statistically significant.
- Study followed 959 COURAGE trial participants for a median of 15 years, with records up to 25 years.
- Published in JAMA in November 2026; presented at the American Heart Association Scientific Sessions.
- Researchers from University of Colorado Anschutz Medical Campus analyzed linked veterans' health records.
- Study covered stable coronary artery disease only; stents remain life-saving in certain emergency heart attacks.

By 25 years, an estimated 93.3% of patients who received an artery-opening procedure had died or suffered a heart attack — barely different from the 91% in the medicine-only group. That is the core result of a long-running study from the University of Colorado Anschutz Medical Campus, published in JAMA in November 2026 and presented at the American Heart Association Scientific Sessions.
For patients with stable coronary artery disease, the finding challenges a widespread assumption: that mechanically opening a narrowed artery will keep heart attacks away years down the road. In this population, over a median follow-up of 15 years — with some records stretching to 25 — the researchers found no statistically significant difference in the combined risk of death or heart attack between the two treatment paths.
What did the researchers actually measure?
The team examined linked medical records for 959 participants in the earlier COURAGE trial, which compared an initial artery-opening procedure plus medical treatment against medical treatment alone. The new analysis is the long-delayed verdict on that comparison: what happens to these patients over decades, not months.
Two numbers carry the weight. The estimated chance of having died or experienced a heart attack by the 25-year mark was 93.3% in the procedure group and 91% in the medicine-only group. The gap falls well short of statistical significance. The researchers stress that these figures describe outcomes across decades of observation, not the risk any one patient faces in the coming months.
What is the disease, and what do the treatments do?
Coronary artery disease develops when fatty material builds up inside the arteries that supply the heart with oxygen-rich blood. Over time, the narrowing can cause chest discomfort, especially during physical activity.
Doctors treat it along two paths:
- Medicines that lower cholesterol, control blood pressure and reduce the chance of blood clots — paired with healthy habits such as not smoking, regular activity and a heart-friendly diet.
- Angioplasty, in which doctors insert a small balloon to widen the narrowed artery and usually place a tiny metal tube called a stent to hold it open.
Angioplasty can improve blood flow and relieve chest pain. The open question was whether it also prevents heart attacks many years later. On that question, this study returns a clear answer: for stable patients, no.
Does this mean stents are useless?
It does not. Two cautions frame the result.
First, stents ease troublesome symptoms, and rapidly opening a blocked artery during certain heart attacks can save lives. That emergency use stands untouched by this research, which examined only people with stable disease — not people in the middle of a medical crisis.
Second, the study has real limits. Its later follow-up relied on veterans' health records, so the findings may not apply equally to every patient, and some events could have been recorded inaccurately. The numbers are best read as strong long-term evidence rather than the final word.
What changes at the bedside?
For practitioners, the practical shift is in how the conversation gets framed. Opening one narrowed artery does not automatically prevent future heart problems; the trial data now support that statement over a 25-year horizon. For stable patients, the choice between a procedure and medicines should turn on symptoms, overall risk and an individual discussion with their doctor — not on an assumption of long-term protection.
The evidence says stents relieve; they do not, by themselves, prevent.
via knowridge.com (Source)
More from Marcus Bennett
Show full bio
News editor covering regulation, policy and their impact on general science news at SciBeat.
426 articles
Nearby plates
- Stents Don't Prevent Heart Attacks in Stable Patients, 25-Year Data Show
- Statins after 70: STREAM trial finds stopping carries measurable risk
- Bodies Show Decline Years Before Heart Attacks and Strokes Strike
- Heart Failure Deaths Double in Younger and Middle-Aged Americans
- Top Blood Pressure Number Under 130 May Protect Aging Hearts